dc.creator | Marcondes F.G. | |
dc.creator | Ferro A.A. | |
dc.creator | Souza-Torsoni A. | |
dc.creator | Sumitani M. | |
dc.creator | Clarke M.J. | |
dc.creator | Franco D.W. | |
dc.creator | Tfouni E. | |
dc.creator | Krieger M.H. | |
dc.date | 2002 | |
dc.date | 2015-06-30T16:45:35Z | |
dc.date | 2015-11-26T15:37:56Z | |
dc.date | 2015-06-30T16:45:35Z | |
dc.date | 2015-11-26T15:37:56Z | |
dc.date.accessioned | 2018-03-28T22:46:23Z | |
dc.date.available | 2018-03-28T22:46:23Z | |
dc.identifier | | |
dc.identifier | Life Sciences. , v. 70, n. 23, p. 2735 - 2752, 2002. | |
dc.identifier | 243205 | |
dc.identifier | 10.1016/S0024-3205(02)01528-X | |
dc.identifier | http://www.scopus.com/inward/record.url?eid=2-s2.0-0037177476&partnerID=40&md5=46145f64934e03e9911a950e9db42a50 | |
dc.identifier | http://www.repositorio.unicamp.br/handle/REPOSIP/101981 | |
dc.identifier | http://repositorio.unicamp.br/jspui/handle/REPOSIP/101981 | |
dc.identifier | 2-s2.0-0037177476 | |
dc.identifier.uri | http://repositorioslatinoamericanos.uchile.cl/handle/2250/1263769 | |
dc.description | Ruthenium(II/III) complexes able to bind and release NO • were tested in vivo, in conscious Wistar rats instrumented for continuous blood pressure (BP) measurement and administration of in bolus injections (5 to 100 nmol/Kg i.v.) of trans-[Ru IICl(NO +)(cyclam)](PF 6) 2 (cyclam-NO) or sodium nitroprusside (SNP). For normotensive rats, cyclam-NO produced a sustained 10% BP reduction of basal MAP during 7 ± 0.4 to 11 ± 0.3 min. In acute hypertensive rats, cyclam-NO produced BP reduction 3-fold larger than in normotensive rats and similar to that of SNP (maximal effect: 41 ± 1.3 vs. 45 ± 2.2 mmHg, respectively). However, the duration of the effect of cyclam-NO was 13 to 21-fold longer than that of SNP. The hypotensive effect of cyclam-NO was fully blocked in presence of continuous infusion of a NO • scavenger, carboxy-PTIO (6 mmol/Kg/min), or of the inhibitor of cGMP activation, methylene blue (83 nmol/Kg/min), or of the cyclam-NO precursor, trans-[RuCl(tfms)(cyclam)](tfms) (cyclam-tfms) (500 mmol/Kg/min). The long lasting BP reduction of cyclam-NO can be interpreted in terms of a slower rate of NO • release (k -NO = 2.2 × 10 -3 s -1 at 35°C) following chemical reduction (E 0′ = 0.10 V vs NHE). In summary, cyclam-NO showed an hypotensive effect around 20 times longer than SNP in either normotensive or hypertensive rats, which was completely inhibited by methylene blue or carboxy-PTIO. Continuous infusion of cyclam-tfms completely blocked the hypotensive effect of cyclam-NO by scavenging the NO • released by the reduced cyclam-NO. © 2002 Elsevier Science Inc. All rights reserved. | |
dc.description | 70 | |
dc.description | 23 | |
dc.description | 2735 | |
dc.description | 2752 | |
dc.description | Ignarro, L.J., (2000) Nitric Oxide: Biology and Pathology, , Orlando: Academic Press | |
dc.description | Whittle, B.J.R., Nitric oxide in physiology and pathology (1995) Hystochem J, 27, pp. 727-737 | |
dc.description | Moncada, S., Higgs, A., The L-arginine: Nitric oxide pathway (1993) New Engl J Med, 329, pp. 2002-2012 | |
dc.description | Rees, D.D., Palmer, R.M.J., Moncada, S., The role of endothelium-derived nitric oxide in the regulation of blood pressure (1989) Proc Natl Acad Sci USA, 86, pp. 3375-3378 | |
dc.description | Moncada, S., Palmer, R.M.J., Higgs, A., Nitric oxide: Physiology, pathophysiology and pharmacology (1991) Pharmacol Rev, 43, pp. 109-142 | |
dc.description | Umans, J.G., Levi, R., The nitric oxide system in circulatory homeostasis and its possible role in hypertensive disorders (1995) Hypertension: Pathology, Diagnosis and Management, 2nd edn., pp. 1083-1095. , Laragh JH, Brenner BM, editors. New York: Raven Press | |
dc.description | Paolocci, N., Biondi, R., Bettini, M., Lee, C.I., Berlowitz, C.O., Rossi, R., Xia, Y., Zweier, J.L., Oxygen radical-mediated reduction in basal and agonist-evoked NO release in isolated rat heart (2001) J Mol Cell Cardiol, 33 (4), pp. 671-679 | |
dc.description | Nakamura, T., Igarashi, R., Kurashima, T., Saito, Y., Hoshino, J., Sumino, H., Sakamoto, H., Nagai, R., Lecithinized superoxide dismutase induces vasodilation | |
dc.description | evidence of direct contribution of superoxide anions to modulating vascular tone (1999) Life Sci, 64, pp. 65-70 | |
dc.description | Clarke, M.J., Gaul, J.B., Chemistry relevant to the biological effects of nitric oxide and metallonitrosyls (1993) Structure and Bonding, 81, pp. 147-180. , New York: Springer-Verlag | |
dc.description | Wink, D.A., Mitchell, J.B., Chemical biology of nitric oxide: Insights into regulatory, cytotoxic and cytoprotective mechanisms of nitric oxide (1998) Free Radic Biol Med, 25, pp. 434-456 | |
dc.description | Kelm, M., Feelisch, M., Spahr, R., Piper, H.-M., Noarck, E., Schrader, J., Quantitative and kinetic characterization of nitric oxide and EDRF released from cultured endothelial cells (1988) Biochem Biophis Res Commun, 154, pp. 236-244 | |
dc.description | Wink, D.A., Ford, P.C., Nitric oxide reactions important to biological systems: A survey of some kinetics investigations (1995) Methods: A Companion to Methods in Enzymology, 7, pp. 14-20. , San Diego: Academic Press | |
dc.description | Arnold, W.P., Longnecker, D.E., Epstein, R.M., Photodegradation of sodium nitroprussiate: Biologic activity and cyanide release (1984) Anesthesiology, 61, pp. 254-260 | |
dc.description | Laursen, J.B., Mulsch, A., Boesgaard, S., Mordvintcev, P., Trautner, S., Gruhn, N., Nielsen-Kudsk, J.E., Aldershvile, J., In vivo nitrate tolerance is not associated with reduced bioconversion of nitroglycerin to nitric oxide (1996) Circulation, 94, pp. 2241-2247 | |
dc.description | Wang, Y.X., Legzdins, P., Poon, J.S., Pang, C.Y., Vasodilator effects of organotransition-metal nitrosyl complexes, novel nitric oxide donors (2000) J Cardiovasc Pharmac, 35, pp. 73-77 | |
dc.description | Fricker, S.P., Ruthenium, nitric oxide and disease. A novel inorganic chemistry approach to drug design (1995) Platinum Metals Rev, 39, pp. 150-159 | |
dc.description | Fricker, S.P., Slade, E., Powell, N.A., Vaughan, O.J., Henderson, G.R., Murrer, B.A., Megson, I.L., Flitney, F.W., Ruthenium complexes as nitric oxide scavengers: A potential therapeutic approaches to nitric oxide-mediated diseases (1997) Br J Pharmacol, 122, pp. 1441-1449 | |
dc.description | Davies, N.A., Wilson, M.T., Slade, E., Fricker, S.P., Murrer, B.A., Powel, N.A., Henderrson, G.R., Kinetics of nitric oxide scavenging by ruthenium(III) polyaminocarboxylates: Novel therapeutic agents for septic shock (1997) Chem Commun, (1), pp. 47-48 | |
dc.description | DeLeo, M.A., Ford, P.C., Photoreactions of coordinated nitrite ion. Reversible nitric oxide labilization from the chromium(III) complex trans-[Cr(cyclam)(ONO) 2] + (2000) Coord Chem Rev, 208, pp. 47-59 | |
dc.description | Bourassa, J.L., Ford, P.C., Flash and continuous photolysis studies of Roussin's red salt dianion Fe 2S 2(NO) 4 2- in solution (2000) Coord Chem Rev, 200, pp. 887-900 | |
dc.description | Works, C.F., Ford, P.C., Photoreactivity of the ruthenium nitrosyl complex, Ru(salen)(Cl)(NO). Solvent effects on the back reaction of NO with the Lewis acid Ru-III(salen)(Cl) (2000) J Am Chem Soc, 122, pp. 7592-7593 | |
dc.description | DeLeo, M.A., Bu, X.H., Bentow, J., Ford, P.C., The synthesis, characterization and structures of the chromium(III) dinitrito complexes: Trans-[Cr(L)(ONO) 2] +(L = 1,4,8,11-tetraazacyclotetradecane or 5,7,7,12,14,14-hexamethyl-1,4,8,11-tetraazacyclotetradecane) (2000) Inorg Chim Acta, 300, pp. 944-950 | |
dc.description | Bourassa, J., Lee, B., Bernhard, S., Schoonover, J., Ford, P.C., Flash photolysis studies of Roussin's black salt anion: Fe 4S 3(NO) 7 - (1999) Inorg Chem, 38, p. 5926 | |
dc.description | Hoshino, M., Laverman, L., Ford, P.C., Nitric oxide complexes of metalloporphyrins: An overview of some mechanistic studies (1999) Coord Chem Rev, 187, pp. 75-102 | |
dc.description | Ford, P.C., Bourassa, J., Miranda, K., Lee, B., Lorkovic, I., Boggs, S., Kudo, S., Laverman, L., Photochemistry of metal nitrosyl complexes. Delivery of nitric oxide to biological targets (1998) Coord Chem Rev, 171, pp. 185-202 | |
dc.description | Laverman, L.E., Ford, P.C., Reactions of water soluble iron(II) and cobalt(II) porphyrins with nitric oxide. Implications for the reactivity of NO and biologically relevant metal centers (1999) Chem Commun, 18, pp. 1843-1844 | |
dc.description | Chen, Y.A., Shepherd, R.E., [Ru II(ttha)(H 2O) 2] 2- is a rapid NO scavenger (ttha 6- = triethylenetetraaminehexaacetate (1997) J Inorg Biochem, 68, pp. 183-193 | |
dc.description | Chen, Y.A., Lin, F.T., Shepherd, R.E., 15N NMR and electrochemical studies of [Ru II(Hhedta)] - complexes of NO, NO +, NO 2 - and NO - (1999) Inorg Chem, 38, pp. 973-983 | |
dc.description | Ward, M.S., Shepherd, R.E., A reversible NO complex of [Fe II(edampda)] and the [Ni II(edampda)] analogue (edampda = N,N′-bis(pyridylmethylenediamina-N,N′-diacetate) (1999) Inorg Chim Acta, 286, pp. 197-206 | |
dc.description | Chen, Y., Sweetland, M.A., Shepherd, R.E., A reversible NO complex of Fe(II)-(TIM): An S = 1/2 (FeNO) 7 nitrosyl (1997) Inorg Chim Acta, 260, pp. 163-172 | |
dc.description | Shepherd, R.E., Sweetland, M.A., Junker, D.E., Ligand field factors in promoting S = 3/2 (FeNO) 7 nitrosyls (1997) J Inorg Biochem, 65, pp. 1-14 | |
dc.description | Bezerra, C.W.B., Silva, S.C., Gambardella, M.T.P., Santos, R.H.A., Plicas, L.M.A., Tfouni, E., Franco, D.W., Water π-donation in trans-tetraammineruthenium(II): Effect on coordinated water properties induced by NO trans ligand (1999) Inorg Chem, 38, pp. 5660-5667 | |
dc.description | Lang, D., Davis, J.A., Lopes, L.G.F., Ferro, A.A., Vasconcellos, L.C.G., Prock, A., Franco, D.W., Clarke, M.J., A controlled NO releasing compound: Synthesis, molecular structure, spectroscopy, electrochemistry, and chemical reactivity of (R,R,S,S) trans-[RuCl(NO)(cyclam)] 2+ (cyclam = 1,4,8,11-tetraazacyclotetradecane) (2000) Inorg Chem, 39, pp. 2394-2400 | |
dc.description | McGarvey, B.R., Ferro, A.A., Tfouni, E., Bezerra, C.W.B., Bagatin, I., Franco, D.W., Detection of the EPR spectrum of NO in ruthenium(II) complexes (2000) Inorg Chem, 39, pp. 3577-3581 | |
dc.description | Gorelsky, S.I., Silva, S.C., Lever, A.B.P., Franco, D.W., Electronic spectra of trans-[Ru(NH 3) 4L(NO)] 3+/2+ complexes (2000) Inorg Chim Acta, 300, pp. 698-708 | |
dc.description | Da Silva, S.C., Franco, D.W., Metastable excited states and electronic structure of [Ru(NH 3) 5(NO)] 3+ and [Ru(NH 3) 4(OH)(NO)] 2+ (1999) Spectrochim Acta A, 55, pp. 1515-1525 | |
dc.description | Lopes, L.G.F., Gomes, M.G., Borges, S.S.S., Franco, D.W., Correlation between the lever parameter and electronic properties of nitrosyl ruthenium(II) complexes (1998) Austr J Chem, 51, pp. 865-866 | |
dc.description | Borges, S.D.S., Davanzo, C.U., Castellano, E.E., Z-Schpector, J., Silva, S.C., Franco, D.W., Ruthenium nitrosyl complexes with N-heterocyclic ligands (1998) Inorg Chem, 37, pp. 2670-2677 | |
dc.description | Gomes, M.G., Davanzo, C.U., Silva, S.C., Lopes, L.G.F., Santos, P.S., Franco, D.W., Cis- and trans-nitrosyltetraammineruthenium(II). Spectral and electrochemical properties and reactivity (1998) J Chem Soc Dalton, pp. 601-607 | |
dc.description | Ferro, A.A., (2000) Síntese, Caracterização e Reatividade Química e Fotoquímica de Aminas de Rutênio (trans-[Ru(NO)(NH 3) 4L](BF 4) 3 (L = pz, 4-acpy, imN ou L-hist) e trans-[RuCl(NO)(cyclam)](PF 6) 2 (cyclam = 1,4,8,11-tetraazaciclotetradecano)), , D.Sc.Thesis, Departamento de Química, Faculdade de Filosofia, Ciências e Letras de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, SP, Brazil | |
dc.description | Tfouni, E., Photochemical reactions of ammineruthenium(II) complexes (2000) Coord Chem Rev, 196, pp. 281-305 | |
dc.description | Callahan, R.W., Meyer, T.J., Reversible electron-transfer in ruthenium nitrosyl complexes (1977) Inorg Chem, 16, pp. 574-581 | |
dc.description | Akaike, T., Yoshida, M., Miyamoto, Y., Sato, K., Kohno, M., Sasamoto, K., Miyazaki, K., Maeda, H., Antagonist action of imidazolineoxyl N-oxides against endothelium-derived relaxing factor/NO through a radical reaction (1993) Biochem, 32, pp. 827-832 | |
dc.description | Mayer, B., Brunner, F., Schmidt, F., Inhibition of the nitric oxide synthesis by methylene blue (1993) Biochem Pharmacol, 45, pp. 367-374 | |
dc.description | Cingi, M.R., De Angelis, I., Fortunati, E., Reggiani, E., Bianchi, V., Tiozzo, R., Zucco, F., Choice standardization of test protocols in cytotoxicology: A multicentre approach (1991) Toxicology In vitro, 5, pp. 119-125 | |
dc.description | Mosmann, T., Rapid colorimetric assay for cellular grownth and survival: Application to proliferation and citotoxicity assays (1983) J Immun Methods, 65, pp. 55-63 | |
dc.description | Frasca, D.R., Clarke, M.J., Alterations in the binding of [Cl(NH 3) 5Ru III] 2+ to DNA by glutathione: Reduction, autoxidation, coordination, and decomposition (1999) J Am Chem Soc, 121, pp. 8523-8532 | |
dc.description | Clarke, M.J., Bitler, S., Rennert, D., Buchbinder, M., Kelman, A.D., Reduction and Subsequent Binding of Ruthenium Ions Catalyzed by Subcellular Components (1980) J Inorg Biochem, 12, pp. 79-87 | |
dc.description | Franco, D.W., Tfouni, E., Krieger, M.H., Toledo J.C., Jr., Barros, B.F., First International Conference. Biology, chemistry, and therapeutic applications of nitric oxide. San Francisco, CA, 2000, in Nitric Oxide (2000) Biology and Chemistry, 4, p. 254 | |
dc.description | Torsoni, A.S., Barros, B.F., Toledo J.C., Jr., Haun, M., Krieger, M.H., Tfouni, E., Franco, D.W., Hypotensive properties and acute toxicity of trans-[Ru(NH 3) 4P(OEt) 3(NO)](PF 6) 3. A new nitric oxide donor Nitric Oxide, , in press | |
dc.description | Kruszyna, H., Kruszyna, R., Hurst, J., Smith, R.P., Toxicology and pharmacology of some ruthenium compounds: Vascular smooth muscle relaxation by nitrosyl derivatives of ruthenium and iridium (1980) J Toxic Envir Health, 6, pp. 757-773 | |
dc.description | Gruetter, C.A., Gruetter, D.Y., Lyon, J.E., Kadowitz, J.P., Ignarro, L.J., Relationship between cyclic guanosine 3:5-monophososphate. Formation and relaxtion of coronary arterial smooth muscle by glyceryl trinitrate, nitropruuside, nitrite and nitric oxide: Effects of methylene blue and methemoglobin (1981) J Pharm Exp Therap, 2199, pp. 181-186 | |
dc.description | Wolin, M.S., Cherry, P.D., Rodenburg, J.M., Messina, E.J., Kaley, G., Methylene blue inhibits vasodilation of skeletal muscle arterioles to acethylcholine and nitric oxide via the extracellular generation of superoxide anion (1990) J Pharm Exp Ther, 254, pp. 872-876 | |
dc.description | Kowaluk, E.A., Seth, P., Fung, H.-L., Metabolic activation of sodium nitroprussitee to nitric oxide in vascular smooth muscle (1992) J Pharm Exp Ther, 262, pp. 916-922 | |
dc.description | Ferreira, K.Q., Tfouni, E., unpublished resultsGuidorzi, A.P.B., Lopes, L.G.F., Franco, D.W., (1997) Reatividade do ligante NO em [RuHedtaNO] 2+/+. 20 a Reunião Annual da SBQ, Poços de Caldas, MG, 1997. Livro de Resumos, 1. , São Paulo, Brazil, abstract QI-121 | |
dc.description | Walker, D.D., Taube, H., N-Macrocyclic complexes of ruthenium(II) and ruthenium(III) (1981) Inorg Chem, 20, pp. 2828-2834 | |
dc.description | Walker, D.D., (1980) Saturated tetraaza macrocyclic ligand complexes of ruthenium(II) and ruthenium(III), , Ph.D. Thesis. Stanford University, Stanford | |
dc.language | en | |
dc.publisher | | |
dc.relation | Life Sciences | |
dc.rights | fechado | |
dc.source | Scopus | |
dc.title | In Vivo Effects Of The Controlled No Donor/scavenger Ruthenium Cyclam Complexes On Blood Pressure | |
dc.type | Artículos de revistas | |